Solar Foods
Series B in 2024
Solar Foods Ltd. is a food-tech startup based in Lappeenranta, Finland, founded in 2017. The company specializes in producing a sustainable protein called Solein, which serves as an alternative to animal-derived proteins. Solein is developed through a unique process that combines electricity, hydrogen, carbon dioxide, water, vitamins, and minerals to cultivate microbial biomass. This method utilizes gas fermentation, allowing the production of edible calories from hydrogen-oxidizing microbes without reliance on traditional agriculture, weather, or climate conditions. Solar Foods aims to provide nutritious food ingredients and plant-based meat alternatives that promote sustainability in food production.
Solar Foods
Series B in 2023
Solar Foods Ltd. is a food-tech startup based in Lappeenranta, Finland, founded in 2017. The company specializes in producing a sustainable protein called Solein, which serves as an alternative to animal-derived proteins. Solein is developed through a unique process that combines electricity, hydrogen, carbon dioxide, water, vitamins, and minerals to cultivate microbial biomass. This method utilizes gas fermentation, allowing the production of edible calories from hydrogen-oxidizing microbes without reliance on traditional agriculture, weather, or climate conditions. Solar Foods aims to provide nutritious food ingredients and plant-based meat alternatives that promote sustainability in food production.
Bioretec
Private Equity Round in 2021
Bioretec Ltd. is a Finnish company specializing in the development, manufacturing, and marketing of bioabsorbable and bioactive surgical implants. These implants are designed for use in orthopedic, trauma, and sports medicine surgeries, catering to both pediatric and adult patients. Bioretec's products, recognized for their safety and reliability, are utilized globally and are engineered for high-load-bearing clinical applications. The company continues to innovate in material technology, with notable brands including RemeOs, Activa IM-N, ActivaPi, and ActivaScrew.
Convion Ltd. is a Finnish company, established in 2012 and located in Espoo, that specializes in the development and manufacturing of solid oxide fuel cells for power generation. The company focuses on creating high-efficiency systems that facilitate distributed power generation and hydrogen production, utilizing various fuels to enhance energy independence and security. Convion's modular fuel cell systems are designed for industrial and commercial applications, offering operational flexibility and reliability. By leveraging solid oxide fuel cell technology, Convion aims to contribute to sustainable energy solutions and improve the efficiency of power generation markets.
Mobidiag
Venture Round in 2018
Mobidiag is a Finnish-French biotechnology company that focuses on developing and marketing innovative molecular diagnostic solutions aimed at detecting gastrointestinal infections, antimicrobial resistance, healthcare-associated infections, respiratory infections, and sepsis. Utilizing established qPCR and microarray technologies, Mobidiag provides a wide array of fast, reliable, and cost-effective diagnostic tests and automated platforms suitable for laboratories of various sizes. Their offerings enable the detection of a broad spectrum of clinically relevant bacteria, parasites, viruses, and antibiotic resistance markers, thereby facilitating quicker diagnosis and treatment in hospitals, laboratories, and clinics.
Ductor is a Finnish biotechnology company specializing in the sustainable production of ammonia and phosphates from recycled materials. The company has developed proprietary technology that can be integrated into various applications, including algae farming, to provide essential nutrients and renewable energy. Ductor aims to address critical challenges such as climate change, increasing food demand, and waste accumulation by offering organic fertilizers and renewable energy derived from biogas. The company has recently achieved a strategic milestone by commencing industrial-scale production, with its first implementation set to enhance the economics of existing biogas production facilities. This innovative approach supports farmers and food producers in maintaining healthy soils and adopting ecological farming practices.
Springvest
Series A in 2017
Springvest is a crowdfunding platform based in Helsinki, Finland, established in 2012. It aims to streamline the financing process for promising Finnish growth companies, allowing them to focus on their business rather than spending excessive time on fundraising. By connecting these companies with investors seeking higher potential opportunities, Springvest facilitates financing rounds that empower businesses to capitalize on their ideas more quickly and effectively. The platform encourages Finnish investors to engage with local growth companies, fostering a community that supports innovation and potential success in the Finnish market.
Ukkoverkot
Series A in 2017
Ukkoverkot Ltd is a Finnish mobile data operator that specializes in the maintenance, sale, and marketing of a 450 MHz 4G LTE mobile data network, which provides nationwide coverage across Finland. The company is dedicated to delivering wireless telecommunication services tailored for businesses, authorities, and other demanding user groups, and does not provide voice or SMS services. In addition to its comprehensive national network, Ukkoverkot offers high-speed mobile network solutions designed to meet both continuous and temporary connectivity needs in specific areas.
CurifyLabs is a Finnish healthtech company that specializes in developing 3D printing solutions for the personalized manufacturing of medicines within pharmacies and hospitals. Founded in 2021 by Charlotta Topelius and Niklas Sandler Topelius, the company offers an automated on-demand manufacturing system known as “the Pharma Kit,” along with printable pharmaceutical inks. This innovative approach enables the mass customization of medications tailored to individual patient needs, enhancing treatment efficacy and safety while significantly reducing costs. By streamlining the drug compounding process, CurifyLabs improves compliance and sustainability in pharmaceutical manufacturing, making personalized medicines readily available on-site in healthcare settings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.